Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 94 composition records across product categories including Home maintenance, Arts and crafts/office supplies, Construction and building materials.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of SHELLAC in our catalog (epa_cpdat).
Products
94
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 94 composition records across product categories including Home maintenance, Arts and crafts/office supplies, Construction and building materials. EPA CPDat classifies this chemical for functional uses including Softener and conditioner, Film former, Viscosity modifier.
US
FDA
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 29 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 75.01 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Potency: 3 mg/1ml
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 112 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 30 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 21.44 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 213.24 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 4.4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, SUGAR COATED; Potency: NA
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as structurallydiverse.